Konjević, Gordana <br/><br/>
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.  [electronic resource] 

 -  Clinical & experimental metastasis  2007 
 - 1-11 p.  digital 
<br/><br/> Publication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0262-0898 
<br/><br/><label>Standard No.: </label>10.1007/s10585-006-9043-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Surface--biosynthesis<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cytotoxicity, Immunologic<br/>Female<br/>Flow Cytometry<br/>History, 17th Century<br/>Humans<br/>Interferon-alpha--pharmacology<br/>Interleukin-2--pharmacology<br/>Killer Cells, Natural--drug effects<br/>Lectins, C-Type--biosynthesis<br/>Lymphocytes--drug effects<br/>Male<br/>Melanoma--immunology<br/>NK Cell Lectin-Like Receptor Subfamily B<br/>NK Cell Lectin-Like Receptor Subfamily K<br/>Neoplasm Metastasis--immunology<br/>Receptors, Immunologic--biosynthesis<br/>Receptors, KIR<br/>Receptors, KIR2DL1<br/>Receptors, KIR2DL3<br/>Receptors, Natural Killer Cell<br/>Recombinant Proteins--pharmacology<br/>Skin Neoplasms--immunology<br/>Tretinoin--pharmacology